Arogya Legal | India | 19 Mar 2024
Dear Reader, We are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy…
Burges Salmon LLP | United Kingdom | 18 Mar 2024
The Government has committed to taking action to remove ethnic and other biases in medical devices. The Department for Health and Social Care (DHSC)…
Covington & Burling LLP | United Kingdom | 15 Mar 2024
On March 11, 2023, the UK Government published its response (“Government Response”) to an independent review on equity in medical devices…
Hogan Lovells | China | 27 Feb 2024
This article aims to introduce three recent regulatory updates in China’s life science sector. These updates involve incentives for…
McDermott Will & Emery | USA | 27 Feb 2024
The US Food & Drug Administration (FDA) recently issued two critical policies aimed at harmonizing medical device quality requirements with…
Arogya Legal | India | 22 Feb 2024
India's Ministry of Health and Family Welfare has notified the Surrogacy (Regulation) Amendment Rules, 2024, which removes the earlier requirement…
Bristows | European Union, United Kingdom | 21 Feb 2024
The AI Act continues to contain a concerning flaw as regards the testing of any high risk AI System that also qualifies as a medical device under the…
Arogya Legal | India | 13 Feb 2024
Dear Reader, We are happy to share the most interesting legal and policy updates concerning health industry that we read today. We hope you enjoy…
Covington & Burling LLP | Germany | 12 Feb 2024
Significant changes are on the horizon for clinical trials in Germany. At the end of January 2024, the German Federal Health Ministry has presented…
Covington & Burling LLP | USA | 9 Feb 2024
On Wednesday, January 31, 2024, FDA announced the publication of a final rule to implement the most significant revisions in FDA’s quality system…